Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. (Q46461320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Jason A Yahwak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Richard R Riker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sarah Subak-Sharpe

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

984-991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene glycol-induced proximal renal tubular cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Serum osmolality in alcohol ingestions: differences in availability among laboratories of teaching hospital, nonteaching hospital, and commercial facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Acute Tubular Necrosis Associated with Propylene Glycol from Concomitant Administration of Intravenous Lorazepam and Trimethoprim‐Sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Osmolality and Osmolarity: Narrowing the Terminology Gap

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Hyponatremia, hyposmolality, and hypotonicity: tables and fables

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Osmol gaps in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Propylene glycol pharmacokinetics and effects after intravenous infusion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Medication vehicle injury--using the proper restraint?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.8.984

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.8.984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18657015%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference